Comparing 3D and 2D heart strain measurements in heart failure patients
Official title: Left Ventricular Myocardial Strain Assessed by Three-dimensional Speckle-tracking Echocardiography in Heart Failure With Reduced and Mildly Reduced Ejection Fraction. A Comparison With Two-dimensional Evaluation in a Prospective Study
Run by Istituti Clinici Scientifici Maugeri SpA · NCT07741305 · Data updated 2026-11-12
This study tests whether 3D speckle-tracking echocardiography provides different or better information than 2D in assessing heart muscle function in people with heart failure and reduced or mildly reduced ejection fraction.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 419 (estimated) |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA Academic / other |
| Locations | 5 sites (Bari, BA and 4 other locations) |
| Status | Recruiting |
| Started | January 8, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT07741305 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with heart failure and LVEF ≤ 49% who can undergo echocardiography with adequate image quality at participating Italian centers.
✕Probably not a fit
Patients with poor acoustic windows, significant arrhythmias preventing multi-beat imaging, or inability to consent may not benefit from these findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study enrolling about 419 adults with heart failure across seven Italian cardiac centers to compare left-ventricular strain measurements from 2D and 3D speckle-tracking echocardiography. Researchers will use standardized equipment and software to determine how closely the two methods agree and what factors influence any differences. The study will also explore whether 3D GLS better predicts mortality risk than 2D GLS. Inclusion requires LVEF ≤ 49% and adequate image quality; several image-acquisition limitations are excluded. No interventions are administered; the study analyzes imaging data collected during routine care.
Why it matters
Potential benefit: If 3D GLS proves more predictive, clinicians may improve risk stratification and management decisions for heart failure patients.
How similar studies have gone: Prior research supports 2D GLS for prognosis in heart failure, with 3D GLS showing potential advantages but limited comparative data in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Left ventricular ejection fraction (LVEF) ≤ 49%; * Echocardiographic image quality judged to be at least adequate according to a four-point visual image quality scale (good, adequate, poor, or inadequate) Exclusion Criteria: * Inability to maintain the correct position for acquiring echocardiographic images; * Arrhythmias that make multi-beat acquisition impossible (if required), such as frequent extrasystoles (supraventricular or ventricular) and atrial fibrillation; * Failure to visualize more than 2 segments of the left ventricle (LV), or inability to assess more than 3 segments during 3D GLS analysis; * Failure to sign the informed consent form and inability of the participant to understand the objectives of the study
Where it's running
-
ICS Maugeri - Istituto di Bari
Bari, Ba, Italy Recruiting -
ICS Maugeri - Istituto di Milano
Milan, Mi, Italy Recruiting -
ICS Maugeri - Istituto di Pavia
Pavia, Pv, Italy Recruiting -
ICS Maugeri Torino
Torino, To, Italy Recruiting -
ICS Maugeri - Istituto di Veruno
Veruno, Italy Recruiting
Study contacts
- Study coordinator: Oronzo Catalano, MD
- Email: oronzo.catalano@icsmaugeri.it
- Phone: +39(0)382592608
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.